[Current status and prospects of maintenance therapy in advanced stage non-small cell lung cancer]

Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):637-41. doi: 10.3779/j.issn.1009-3419.2010.06.013.

[Article in Chinese]

Authors

Lin Quan¹, Wenping Chen, Yongqian Shu

Affiliation

¹ Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.

PMID: 20681454
PMCID: PMC6015163
DOI: 10.3779/j.issn.1009-3419.2010.06.013

No abstract available

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / therapy*
ErbB Receptors / antagonists & inhibitors
Humans
Immunotherapy
Lung Neoplasms / pathology
Lung Neoplasms / therapy*
Neoplasm Staging
Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

Vascular Endothelial Growth Factor A
ErbB Receptors